All News

First season of makeover show follows 5 pharmacies building immunization programs.

Although naloxone is already available without a prescription in all 50 states, not all pharmacies carry it and those that do must keep it behind the counter.

Because of CRS and neurologic toxicity risk, the therapy is available through a REMS program.

Declining and inconsistent use of blood-pressure, glucose-, and lipid-lowering medications for those with type 2 diabetes suggests treatment gaps, investigators say.

Pharmacies have long embraced innovation and technology, with early adoption of telehealth and digital platforms.

Patients with heart failure are at a significant risk of cardiorenal diseases, highlighting the need for improved treatments and cost management.

Link between male or female sex and the severity of COVID-19 may be found in a subset of regulatory T cells.

More than 90 minutes of varied sleep time may also increase a person’s risk of developing hardened arteries.

New data identifying a particular gene expression signature will be presented at the 2023 ASCO Genitourinary Symposium.

Past proposal gives insight into lawmakers' thinking about medicinal use of cannabis on a federal level.

Under the EUA, the Xpert Mpox test is considered authorized for use in moderately complex point-of-care settings using the GeneXpert Xpress system.

Students may be hesitant to discuss migraines, which can lead to absences, difficulties in personal life, financial burdens, and poor mental health.

Both indications for the CTLA-4 inhibitor were approved by the FDA in 2022.

Data from 52 studies show that antimicrobial stewardship programs largely reduced antibiotic use for pediatric care.

The drive for personalized approaches to cancer have helped to create treatments for patients with rare cancers who have few, if any, options.

Those seeking abortion were found to have triple the risk of a psychiatric disorder compared to the general population.

Their exclusion ripples into demand estimates for pharmacists, leading to a distorted picture of pharmacist demand and, ultimately, impacting the number of individuals choosing to enter the profession.

US adults have a slightly stronger preference for fewer adverse events in relation to pediatric COVID-19 vaccination, study results show.

Idecabtagene vicleucel prolonged progression-free survival by more than 1 year in a difficult-to-treat patient population with relapsed or refractory multiple myeloma.

Association of Black Health-System Pharmacists focuses on advocacy, collaboration, education, leadership, and research.

Analysis shows average monthly premiums for stand-alone plans will rise 10% to $43.

Relative efficacy of nirmatrelvir–ritonavir appears similar across risk groups, but older adults at risk of severe COVID-19 may benefit more.

Study findings confirmed that in asthma, chronic obstructive pulmonary disease, HIV, and influenza, census data differed from the epidemiological data.

The new findings, which include updated data, contradict results of a previous analysis by the same investigators.

Although investigative team is predominantly investigating Priscilicidin for topical applications, they are not ruling out potential oral applications.

HER2-low disease demands a different approach from that of HER2-negative disease.

Amanda Ryan, the director of Education for the Pharmacy Quality Alliance (PQA), discusses a new PQA program to teach pharmacy and other health professions students the basics of quality measurement and strategies to improve medication safety, adherence and appropriate use.

The patient's list of medications reveals significant drug interactions to be addressed.

Study shows no robust differences in blood pressure, heart rate, lipids, and glucose measurements in children conceived using assisted reproductive technologies.

Results of 2 phase 3 clinical trials demonstrate better response rate beyond the primary endpoint analysis at week 16 to more than 55 at week 55.